Biontech Se Drn Stock Five Year Return
| B1NT34 Stock | BRL 45.28 0.68 1.52% |
BIONTECH SE DRN fundamentals help investors to digest information that contributes to BIONTECH's financial success or failures. It also enables traders to predict the movement of BIONTECH Stock. The fundamental analysis module provides a way to measure BIONTECH's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to BIONTECH stock.
BIONTECH |
BIONTECH SE DRN Company Five Year Return Analysis
BIONTECH's Five Year Return is considered one of the best measures to evaluate fund performance, especially from the mid and long term perspective. It shows the total annualized return generated from holding equity for the last five years and represents capital appreciation of the investment, including all dividends, losses, and capital gains distributions.
More About Five Year Return | All Equity Analysis
Five Year Return | = | (Mean of Monthly Returns - 1) | X | 100% |
Although Five Year Returns can give a sense of overall investment potential, it is recommended to compare equity performance with similar assets for the same five year time interval. Similarly, comparing overall investment performance over the last five years with the appropriate market index is a great way to determine how this equity instrument will perform during unforeseen market fluctuations.
| Competition |
According to the company disclosure, BIONTECH SE DRN has a Five Year Return of 0.0%. This indicator is about the same for the Healthcare average (which is currently at 0.0) sector and about the same as Biotechnology (which currently averages 0.0) industry. This indicator is about the same for all Brazil stocks average (which is currently at 0.0).
Did you try this?
Run Idea Analyzer Now
Idea AnalyzerAnalyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas |
| All Next | Launch Module |
BIONTECH Fundamentals
| Return On Equity | 0.76 | |||
| Return On Asset | 0.43 | |||
| Profit Margin | 0.56 % | |||
| Operating Margin | 0.68 % | |||
| Current Valuation | 165.09 B | |||
| Shares Outstanding | 3.88 B | |||
| Price To Book | 2.30 X | |||
| Price To Sales | 12.63 X | |||
| Revenue | 18.98 B | |||
| Gross Profit | 16.07 B | |||
| EBITDA | 15.13 B | |||
| Net Income | 10.29 B | |||
| Total Debt | 171.6 M | |||
| Book Value Per Share | 76.45 X | |||
| Cash Flow From Operations | 889.7 M | |||
| Earnings Per Share | 13.87 X | |||
| Price To Earnings To Growth | 0.01 X | |||
| Number Of Employees | 4 K | |||
| Beta | 0.2 | |||
| Market Capitalization | 184.35 B | |||
| Total Asset | 15.83 B | |||
| Annual Yield | 0.01 % | |||
| Net Asset | 15.83 B |
About BIONTECH Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze BIONTECH SE DRN's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of BIONTECH using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of BIONTECH SE DRN based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in BIONTECH Stock
BIONTECH financial ratios help investors to determine whether BIONTECH Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in BIONTECH with respect to the benefits of owning BIONTECH security.